SCHEMBL8009352

SCHEMBL8009352

Cc1ccc(OC[C@@H]2CO2)cc1C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.65
TP53 P04637 3/20 0.65
TSHR P16473 3/20 0.65
HIF1A Q16665 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
CYP3A4 P08684 1/20 0.65
MAPT P10636 3/20 0.57
HPGD P15428 3/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
CYP1A2 P05177 1/20 0.57
PPARG P37231 1/20 0.57
TDP1 Q9NUW8 1/20 0.56
PKM P14618 2/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
GLA P06280 1/20 0.51
FGFR1 P11362 1/20 0.46
SRC P12931 1/20 0.46
FKBP1A P62942 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8009353 1.00 ALDH1A1 (0.65) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL3138518 1.00 ALDH1A1 (0.65) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL9840140 0.87 TSHR (0.50) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL30277376 0.86 ALDH1A1 (0.62) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL11871495 0.86 ALDH1A1 (0.62) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL1357057 0.86 ALDH1A1 (0.62) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL3123349 0.84 ALDH1A1 (0.59) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL15613979 0.84 ALDH1A1 (0.59) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL7279015 0.84 ALDH1A1 (0.59) ALDH1A1TP53TSHRHIF1ASMN1; SMN2
SCHEMBL29847574 0.84 ALDH1A1 (0.59) ALDH1A1TP53TSHRHIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015004485-A1 THERAPEUTIC COMPOUNDS ISIS INNOVATION LIMITED (GB) 2015-01-15 WO disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed